Cargando…

CNS inflammatory demyelinating events after COVID-19 vaccines: A case series and systematic review

BACKGROUND: Vaccinations provided the most effective tool to fight the SARS-CoV-2 pandemic. It is now well established that COVID-19 vaccines are safe for the general population; however, some cases of rare adverse events following immunization have been described, including CNS Inflammatory Demyeli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rinaldi, Virginia, Bellucci, Gianmarco, Buscarinu, Maria Chiara, Reniè, Roberta, Marrone, Antonio, Nasello, Martina, Zancan, Valeria, Nistri, Riccardo, Palumbo, Roberto, Salerno, Antonio, Salvetti, Marco, Ristori, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752005/ https://www.ncbi.nlm.nih.gov/pubmed/36530641 http://dx.doi.org/10.3389/fneur.2022.1018785

Ejemplares similares

Late-Onset MS: Disease Course and Safety-Efficacy of DMTS
por: Buscarinu, Maria Chiara, et al.
Publicado: (2022)

Multiple Sclerosis and SARS-CoV-2: Has the Interplay Started?
por: Bellucci, Gianmarco, et al.
Publicado: (2021)

SARS-CoV-2 meta-interactome suggests disease-specific, autoimmune pathophysiologies and therapeutic targets
por: Bellucci, Gianmarco, et al.
Publicado: (2020)

Multiple sclerosis genetic and non-genetic factors interact through the transient transcriptome
por: Umeton, Renato, et al.
Publicado: (2022)

A Case of Double Standard: Sex Differences in Multiple Sclerosis Risk Factors
por: Angeloni, Benedetta, et al.
Publicado: (2021)

MAIT Cells and Microbiota in Multiple Sclerosis and Other Autoimmune Diseases
por: Mechelli, Rosella, et al.
Publicado: (2021)

Case Report: Anti-NMDAR Encephalitis With Anti-MOG CNS Demyelination After Recurrent CNS Demyelination
por: Ren, Bing-Yan, et al.
Publicado: (2021)

Intestinal Permeability and Circulating CD161+CCR6+CD8+T Cells in Patients With Relapsing–Remitting Multiple Sclerosis Treated With Dimethylfumarate
por: Buscarinu, Maria C., et al.
Publicado: (2021)

Case Report: Multiple Sclerosis Relapses After Vaccination Against SARS-CoV2: A Series of Clinical Cases
por: Nistri, Riccardo, et al.
Publicado: (2021)

Reworking GWAS Data to Understand the Role of Nongenetic Factors in MS Etiopathogenesis
por: Mechelli, Rosella, et al.
Publicado: (2020)

COVID-19 and the risk of CNS demyelinating diseases: A systematic review
por: Lotan, Itay, et al.
Publicado: (2022)

CNS demyelinating events in primary Sjögren's syndrome: A single-center case series on the clinical phenotype
por: Afzali, Ali M., et al.
Publicado: (2023)

The value of Interferon β in multiple sclerosis and novel opportunities for its anti-viral activity: a narrative literature review
por: Bellucci, Gianmarco, et al.
Publicado: (2023)

Sentinel inflammatory demyelinating lesions preceding primary CNS lymphoma
por: TORRES, Danielle Mesquita, et al.
Publicado: (2021)

Clinical and Prognostic Analysis of Autoantibody-Associated CNS Demyelinating Disorders in Children in Southwest China
por: Li, Ziyan, et al.
Publicado: (2021)

Genome-Wide Multiple Sclerosis Association Data and Coagulation
por: La Starza, Sara, et al.
Publicado: (2019)

Peripheral Biomarkers in Manifest and Premanifest Huntington’s Disease
por: Morena, Emanuele, et al.
Publicado: (2023)

Para and Post-COVID-19 CNS Acute Demyelinating Disorders in Children: A Case Series on Expanding the Spectrum of Clinical and Radiological Characteristics
por: Khair, Abdulhafeez M, et al.
Publicado: (2022)

Circulating hsa-miR-323b-3p in Huntington's Disease: A Pilot Study
por: Ferraldeschi, Michela, et al.
Publicado: (2021)

Blunted Post-COVID-19 Humoral Immunity in Patients With CNS Demyelinating Disorders on Anti-CD20 Treatments
por: Money, Kelli M., et al.
Publicado: (2022)

Drugs Used in the Treatment of Multiple Sclerosis During COVID-19 Pandemic: A Critical Viewpoint
por: Alborghetti, Marika, et al.
Publicado: (2022)

Autoimmune Encephalitis and CSF Anti-GluR3 Antibodies in an MS Patient after Alemtuzumab Treatment
por: Buscarinu, Maria Chiara, et al.
Publicado: (2019)

Drug Holiday of Interferon Beta 1b in Multiple Sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferiority
por: Romano, Silvia, et al.
Publicado: (2019)

Myelitis features and outcomes in CNS demyelinating disorders: Comparison between multiple sclerosis, MOGAD, and AQP4-IgG-positive NMOSD
por: Fadda, Giulia, et al.
Publicado: (2022)

Should we treat pediatric radiologically isolated syndrome? An 18-year follow-up case report
por: Barbuti, Elena, et al.
Publicado: (2023)

The Contribution of Gut Barrier Changes to Multiple Sclerosis Pathophysiology
por: Buscarinu, Maria Chiara, et al.
Publicado: (2019)

Aging in multiple sclerosis: from childhood to old age, etiopathogenesis, and unmet needs: a narrative review
por: Capasso, Nicola, et al.
Publicado: (2023)

Current Progress in CNS Imaging of Myotonic Dystrophy
por: Minnerop, Martina, et al.
Publicado: (2018)

Recurrent Catatonia and Demyelinating Disorders
por: Jiang, Stephanie M, et al.
Publicado: (2023)

CNS Demyelination with TNF-α Blockers
por: Kemanetzoglou, Elissavet, et al.
Publicado: (2017)

Editorial: Epidemiology of Atypical Demyelinating Diseases
por: Rotstein, Dalia, et al.
Publicado: (2021)

Rebound After Fingolimod and a Single Daclizumab Injection in a Patient Retrospectively Diagnosed With NMO Spectrum Disorder—MRI Apparent Diffusion Coefficient Maps in Differential Diagnosis of Demyelinating CNS Disorders
por: Wagner, Franca, et al.
Publicado: (2018)

The Role of Peripheral CNS-Directed Antibodies in Promoting Inflammatory CNS Demyelination
por: Kinzel, Silke, et al.
Publicado: (2017)

Phenotyping variants of tumefactive demyelinating lesions according to clinical and radiological features—A case series
por: Boyle, Thérèse, et al.
Publicado: (2023)

Chronic Inflammatory or Chronic Inflammatory Demyelinating Polyradiculoneuropathy?
por: Vallat, Jean-Michel, et al.
Publicado: (2022)

Editorial: Neuropathology of Autoimmune Inflammatory Demyelination Disorders
por: Zeitelhofer, Manuel, et al.
Publicado: (2022)

Editorial: Demyelinating neurological syndromes: The role of autoimmunity
por: Evangelopoulos, Maria Eleftheria, et al.
Publicado: (2023)

Basic Spatiotemporal Gait Variables of Young and Older Healthy Volunteers Walking Along a Novel Figure-of-8 Path
por: Zancan, Arturo, et al.
Publicado: (2021)

Deciphering the Footprints of Autoimmunity in CNS Demyelinating Disorders
por: Netravathi, M
Publicado: (2022)

Peripheral Demyelinating Diseases: From Biology to Translational Medicine
por: Kamil, Khidhir, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_k0h0ud7u97jiapn5t7q1191sr1